首页> 外文期刊>Journal of Immune Based Therapies Vaccines >Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model
【24h】

Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model

机译:使用体外PBMC模型评估BCG疫苗重复刺激的免疫应答

获取原文
           

摘要

Background Tuberculosis (TB) is one of the most prevalent cause of death due to a single pathogen. Bacillus Calmette Guérin (BCG) is the only vaccine available for clinical use that protects against miliary TB; however, this vaccine has shown variable levels of efficacy against pulmonary TB. In India, a single dose of BCG vaccine is given and there are few countries where repeated doses of BCG are given. The incidence of TB in India is very high inspite of primary vaccination in neonatal period and therefore requires consideration for repeated immunization. Methods To improve BCG immunogenicity, we have evaluated specific antimycobacterial immune responses (anti-BCG IgG and IFN-γ), T cell activity-ADA, CD4 and CD8 T cell count, and CD4/CD8 ratio in a peripheral blood mononuclear cells (PBMC) model using boost immunization protocols with the BCG vaccine. PBMC were induced with a repeat dose of BCG at 24 and 72 hrs of cell culture. Results At the end of the experimental time, supernatant was collected to estimate anti-BCG IgG titer, interferon γ, ADA activity, CD 4 and CD8 T cell count, and CD4/CD8 ratio. We demonstrated that PBMC induced with a repeat dose of BCG showed an increased specific anti-mycobacterial immune responses, T cell activity, and ADA activity as compared to PBMC induced with BCG alone or without BCG induction. Conclusion The repeat BCG stimulation of PBMC obtained from BCG vaccinated individuals shows enhanced immune activation with respect to increased anti-BCG titre, IFN-γ and ADA activity without concomitant increase in CD4 and CD8 cells. This study provides some basic data in future experiments in animal models with respect to repeat BCG vaccination.
机译:背景结核病(TB)是由单一病原体引起的最普遍的死亡原因之一。卡介苗芽孢杆菌(BCG)是唯一可用于临床的抗粟粒性结核病的疫苗。但是,这种疫苗对肺结核的疗效显示出不同的水平。在印度,单剂卡介苗疫苗被接种,很少国家重复接种卡介苗。尽管在新生儿期初次接种疫苗,印度的结核病发病率仍很高,因此需要考虑重复接种。方法为了提高BCG免疫原性,我们评估了外周血单核细胞(PBMC)的特异性抗分枝杆菌免疫应答(抗BCG IgG和IFN-γ),T细胞活性-ADA,CD4和CD8 T细胞计数以及CD4 / CD8比值)使用BCG疫苗加强免疫方案的模型。在细胞培养的第24和72小时,用重复剂量的BCG诱导PBMC。结果在实验时间结束时,收集上清液以估计抗BCG IgG效价,干扰素γ,ADA活性,CD 4和CD8 T细胞计数以及CD4 / CD8比率。我们证明,与单独使用BCG或不使用BCG诱导的PBMC相比,重复剂量的BCG诱导的PBMC显示出增加的特异性抗分枝杆菌免疫反应,T细胞活性和ADA活性。结论从接种BCG疫苗的个体获得的PBMC的反复BCG刺激显示出增强的免疫激活,这与增加的抗BCG滴度,IFN-γ和ADA活性有关,而CD4和CD8细胞却没有随之增加。这项研究为以后的动物模型重复BCG疫苗接种提供了一些基础数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号